Suppr超能文献

中国大陆人群中使用氨苯砜的N-乙酰化表型分析。

N-acetylation phenotyping with dapsone in a mainland Chinese population.

作者信息

Horai Y, Zhou H H, Zhang L M, Ishizaki T

机构信息

Division of Clinical Pharmacology, National Medical Center, Tokyo, Japan.

出版信息

Br J Clin Pharmacol. 1988 Jan;25(1):81-7. doi: 10.1111/j.1365-2125.1988.tb03285.x.

Abstract

1 The N-acetylation of dapsone (DDS) was studied in 108 unrelated Chinese subjects residing in the mainland of China. 2 The frequency of slow acetylators determined using the plasma monoacetyldapsone to DDS ratio (MADDS/DDS, slow acetylators less than 0.30 and rapid acetylators greater than 0.35) at 3 h after an oral dose of DDS (100 mg) was 13.0% (14 of the 108 subjects) with a 95% confidence interval of 7.9 to 20.6%. 3 The mean plasma concentration of MADDS was about three times lower in the slow than in the rapid acetylators and there was a highly significant correlation (rs = 0.886, P less than 0.001) between plasma MADDS concentration and acetylation ratio. 4 Urinary acetylation ratios (MADDS/DDS) and cumulative urinary excretion of MADDS were significantly (P less than 0.001) lower in slow acetylators compared with rapid acetylators. In addition, there was a significant relationship (rs = 0.510 to 0.718, P less than 0.001) between plasma and urinary acetylation ratios. However, the distribution of the urinary acetylation ratio was not bimodal. 5 The urinary acetylation ratio after an oral dose of DDS is not a discriminative index for determining acetylation phenotype.

摘要
  1. 对居住在中国内地的108名无亲缘关系的中国受试者进行了氨苯砜(DDS)的N - 乙酰化研究。

  2. 口服DDS(100mg)后3小时,使用血浆单乙酰氨苯砜与DDS的比值(MADDS/DDS,慢乙酰化者小于0.30,快乙酰化者大于0.35)确定慢乙酰化者的频率为13.0%(108名受试者中的14名),95%置信区间为7.9%至20.6%。

  3. 慢乙酰化者的MADDS平均血浆浓度比快乙酰化者低约三倍,血浆MADDS浓度与乙酰化比值之间存在高度显著相关性(rs = 0.886,P小于0.001)。

  4. 与快乙酰化者相比,慢乙酰化者的尿乙酰化比值(MADDS/DDS)和MADDS的累积尿排泄量显著更低(P小于0.001)。此外,血浆和尿乙酰化比值之间存在显著关系(rs = 0.510至0.718,P小于0.001)。然而,尿乙酰化比值的分布并非双峰分布。

  5. 口服DDS后的尿乙酰化比值不是确定乙酰化表型的鉴别指标。

相似文献

2
N-acetylation polymorphism of dapsone in a Japanese population.日本人群中氨苯砜的N-乙酰化多态性
Br J Clin Pharmacol. 1988 Apr;25(4):487-94. doi: 10.1111/j.1365-2125.1988.tb03333.x.
9
Disposition of dapsone and monoacetyldapsone in rats.
Proc Soc Exp Biol Med. 1975 Nov;150(2):485-92. doi: 10.3181/00379727-150-39062.
10
Acedapsone treatment of leprosy patients: response versus drug disposition.
Am J Trop Med Hyg. 1977 Jan;26(1):127-36. doi: 10.4269/ajtmh.1977.26.127.

本文引用的文献

3
Genetic control of isoniazid metabolism in man.人体中异烟肼代谢的遗传控制。
Br Med J. 1960 Aug 13;2(5197):485-91. doi: 10.1136/bmj.2.5197.485.
4
Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method.
Eur J Clin Pharmacol. 1980 Feb;17(2):129-33. doi: 10.1007/BF00562621.
6
Dapsone in saliva and plasma of man.人唾液和血浆中的氨苯砜。
Pharmacology. 1981;22(3):162-71. doi: 10.1159/000137486.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验